Cardiac Marker Testing Market: Advancing Diagnostics in Cardiovascular Care
The global Cardiac Marker Testing Market is experiencing a significant transformation, driven by rising cardiovascular disease (CVD) incidence, growing awareness of early diagnosis, and advancements in point-of-care (POC) testing technologies. Cardiac marker tests, essential tools in diagnosing myocardial infarction (MI), heart failure, and other heart-related conditions, are witnessing growing demand across both developed and emerging economies. As healthcare systems strive for early detection and improved patient outcomes, the market is poised for robust growth over the next decade. Market Overview and Size The Cardiac Marker Testing Market Size is expected to register a CAGR of 9.1% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. The market encompasses several types of biomarkers including troponin, creatine kinase-MB (CK-MB), myoglobin, BNP (B-type natriuretic peptide), and others , each playing a s...